COVID-19 THERAPEUTICS ACCELERATOR
COVID-19 Therapeutics Accelerator is a philanthropic collaboration supporting efforts to research, develop and bring effective treatments.
COVID-19 THERAPEUTICS ACCELERATOR
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-12-07 | Sosei Group | COVID-19 Therapeutics Accelerator investment in Grant - Sosei Group | N/A |
More informations about "COVID-19 Therapeutics Accelerator"
Frequently Asked Questions - COVID-19 Therapeutics Accelerator
The COVID-19 Therapeutics Accelerator (CTA) was launched in March 2020 by Wellcome Trust, the Bill & Melinda Gates Foundation and Mastercard, with additional funding from a range of …See details»
COVID-19 Therapeutics Accelerator - Bill & Melinda Gates …
The COVID-19 Therapeutics Accelerator will work with the World Health Organization, government and private sector funders and organizations, as well as the global regulatory and …See details»
What is the ACT-Accelerator - World Health Organization (WHO)
The Access to COVID-19 Tools (ACT) Accelerator, is a new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, …See details»
COVID-19 Therapeutics Accelerator | World Economic …
The COVID-19 Therapeutics Accelerator will work with the World Health Organization, government and private sector funders and organizations, as well as the global regulatory and policy-setting institutions. The Accelerator will …See details»
ACT-Accelerator update - World Health Organization …
Jun 26, 2020 The therapeutics pillar is led by Unitaid and the Wellcome Trust (on behalf of the COVID-19 Therapeutics Accelerator) and seeks to accelerate the development and equitable delivery of treatments at all stages of disease, …See details»
Wellcome pledges $50 million to the …
The COVID-19 Therapeutics Accelerator will work closely with the World Health Organization, government and private sector funders, and global regulatory and policy-setting institutions. It …See details»
Announcing the COVID-19 Therapeutics …
Mar 8, 2020 Mark Suzman announces the COVID-19 Therapeutics Accelerator, a partnership between the Bill & Melinda Gates Foundation, Wellcome, and Mastercard. The …See details»
Investments Made - COVID-19 Therapeutics Accelerator
Started in March in Quebec and has since expanded to Spain, New York and California. This trial is targeting 6,000 outpatients using Colchicine to treat mild COVID-19. Given positive interim …See details»
COVID-19 Therapeutics Accelerator | Most Influential Projects
For letting the science lead the funding on potential COVID-19 treatments. Backed by major players ranging from Mastercard to The Bill & Melinda Gates Foundation to Wellcome, the …See details»
COVID-19 Therapeutics Accelerator Donors Launch International …
The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate …See details»
COVID-19 Therapeutics Accelerator | Research Funding
Apr 19, 2022 The COVID-19 Therapeutics Accelerator is a philanthropic initiative designed to coordinate R&D efforts, remove barriers to drug development and scale up treatments to …See details»
Why Do We Still Need to Invest in COVID-19 Treatments? - Global …
The COVID-19 Therapeutics Accelerator is aligned with the ACT-Accelerator Therapeutics Pillar. To ensure effective treatments reach people in low- and middle-income countries, the COVID …See details»
CTA Donors - COVID-19 Therapeutics Accelerator
Founding and Core Donors Partnership is more important now than ever before. The Gates Foundation, Wellcome Trust, and Mastercard each committed seed funding to speed-up the …See details»
What is the ACT-Accelerator Therapeutics partnership? | News
Oct 29, 2020 The ACT-Accelerator is a groundbreaking global collaboration to accelerate development, production, and equitable access to Covid-19 tests, treatments and vaccines, …See details»
CZI Commits $25 Million to Speed Development of COVID-19 …
Mar 27, 2020 CZI committed $25 million to the COVID-19 Therapeutics Accelerator — a global effort to help speed the development of treatments for the novel coronavirus in partnership …See details»
COVID-19 Therapeutics Accelerator Awards $20 Million in Initial …
SEATTLE, March 30, 2020 – Today, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions—the University of Washington, University …See details»
COVID-19 Therapeutics Accelerator awards | Press release
Mar 30, 2020 Investing now, at scale, in the COVID-19 Therapeutics Accelerator is vital if we are to change the course of this pandemic.” Advancing immunological therapies. In addition to …See details»
Propose a Treatment or Study - COVID-19 Therapeutics Accelerator
The COVID-19 Therapeutics Accelerator has prioritized proposals based on the following scoping criteria. Solutions should have suitability for low-resource settings, with global access through …See details»
Health Product Manufacturers and Innovators COVID-19 Impact …
Feb 26, 2025 Another example of fruitful public-private partnerships during the pandemic is the Gates Foundation/Wellcome Trust/MasterCard COVID-19 Therapeutics Accelerator [101], …See details»
SARS-Cov-2 vaccination strategies in hospitalized recovered …
3 days ago The VATICO study randomized 66 hospitalized recovered COVID-19 individuals to receive either immediate or deferred vaccination, with one or two doses of mRNA SARS-CoV …See details»